Indian Supreme Court stops Glenmark from making generic Januvia

18-05-2015

Indian Supreme Court stops Glenmark from making generic Januvia

Photo: Courtesy of Glenmark Pharamaceuticals Ltd.

The Supreme Court of India has ordered Glenmark Pharmaceuticals to stop making generic versions of Merck Sharp & Dohme’s diabetes drugs Januvia (sitagliptin) and Janumet (sitagliptin and metformin hydrochloride).


Supreme Court of India, patent infringement, MSD, Glenmark, Januvia, Janumet

LSIPR